Preventing ‘cytokine storm’ may ease severe COVID-19 symptoms
Mid-Market Update: Unimpressive US data, China’s Countermeasures, Oil higher and Gold lower on Manufacturing recovery
Novavax’s COVID-19 Vaccine Candidate Could Be the One, Says Top Analyst
3 "Strong Buy" Biotech Stocks Under $5 With Massive Upside Potential
Markets Are Desperate for News About a COVID-19 Vaccines
Airway Therapeutics, Celonic Group partner to produce AT-100 as candidate for coronavirus
AstraZeneca Can Make Up To 1B Covid-19 Vaccine Doses, Signs First Supply Pacts
Can Moderna Win the COVID-19 Vaccine Race?
Inovio Pops Almost 10% on ‘Positive’ Preclinical Results For Its Covid-19 Vaccine
Coronavirus – weekly update – 20 May 2020
BIDMC-developed vaccines protect against COVID-19 in non-human primates, study finds
Revance Acquires HintMD In All-Stock Deal, Analyst Praises Bold Step Forward
Fed Funds Futures No Longer Imply Negative Rates
Aldeyra Explodes 30% After-Hours Ahead Of Covid-19 Update Today
Cisco’s Results Disappoint, Revealing a Challenging April
Beware expensive equity raises
China Leaves Rates Unchanged. Japan Machinery Orders Rebound
Menlo Therapeutics is a Must-Watch Ahead of June PDUFA Date, Says Analyst
Cassava Sciences (SAVA): Let’s Shed Some Light on That Crash
Has Novavax (NVAX) Stock Come Too Far, Too Fast?
Prellis Bio’s Externalized Human Immune System rapidly generates 300 SARS-CoV2 antibodies
Small Biz Oppose Corporate Immunity Push
Moderna stock volatile amid work on coronavirus vaccine
Statistical approach to COVID-19 clinical trials aims to accelerate drug approval process
Donald Trump Wants To Cut The Funding For The WHO
Pfizer Seeks To Raise $4 Billion From Debt Sale
Dynavax Explodes 40% In Pre-Market On Phase 1 Covid-19 Vaccine News
X-ray experiments zero in on COVID-19 antibodies
Daily market commentary: COVID-19 vaccination rumours diminishing investors’ appetite for safe haven assets
Novavax Seeks To Raise $250 Million From Share Sale; Top Analyst Bumps Up PT